{'fraction_non_alphanumeric': 0.02854230377166157, 'fraction_numerical': 0.020387359836901122, 'mean_word_length': 5.061728395061729, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A Dedicated Team Approach Enhances Outcomes of Osteomyelitis Treatment

To assess the impact of a dedicated musculoskeletal infection team, 70 musculoskeletal infections (traumatic and non-traumatic chronic osteomyelitis, Cierny-Mader Type III or IV) in 58 patients with were treated in two groups. Group I (43 infections) was treated with the assistance of an on-call infectious disease specialist. Group II (27 infections) was treated with the assistance of a dedicated musculoskeletal infectious disease specialist. Overall, there was a 42% success in Group I compared with 78% success in Group II. When stratified by infection type, in patients with Type III infections, there was a 56% success in Group I and a 90% success rate in Group II. For patients with Type IV infections, there was a 25% success rate in Group I and a 71% success rate in Group II. The participation of the dedicated musculoskeletal infectious disease specialist significantly improved patient outcomes.